An international study assessing the frequency and risk factors for, disease flare following COVID-19 vaccination in patients with systemic rheumatic disease
Latest Information Update: 27 Apr 2022
At a glance
- Drugs AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 27 Apr 2022 New trial record
- 23 Apr 2022 Results published in the Rheumatology